Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

531

HTML

7527

Figures (1-1)

221

Tables (1-3)

215

Sum=8494

Nov 26, 2011 (publication date) through Jul 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Nov 26, 2011; 3(11): 351-358
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.351

Full Size Figure Download Figure

Figure 1 Mechanism of action and metabolism of warfarin. VKORC1: Vitamin K epoxide reductase enzyme.

Citation: Rubboli A, Becattini C, Verheugt FW. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol 2011; 3(11): 351-358
URL: https://www.wjgnet.com/1949-8462/full/v3/i11/351.htm
DOI: https://dx.doi.org/10.4330/wjc.v3.i11.351